多发性骨髓瘤的生活质量与支持性护理
Quality of life and supportive care in multiple myeloma.
作者信息
Cömert Melda, Güneş Ajda Ersoy, Sahin Fahri, Saydam Güray
机构信息
Ege University School of Medicine, Department of Hematology, İzmir, Turkey.
出版信息
Turk J Haematol. 2013 Sep;30(3):234-46. doi: 10.4274/Tjh.2012.0192. Epub 2013 Sep 5.
UNLABELLED
Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to improvement in survival. Current myeloma management is matching the progress made in improved survival through disease control while optimising quality of life with effective supportive care. Supportive treatment is an essential part of the therapeutic management of myeloma patients because it is directed towards improving the patient's quality of life and also can improve survival. The aim of this review is to highlight the relationship among life of quality, supportive care, and improvement in survival.
CONFLICT OF INTEREST
None declared.
未标注
多发性骨髓瘤是第二常见的血液系统恶性肿瘤。新型疗法已使生存率得到提高。目前的骨髓瘤管理在通过疾病控制实现生存率提高的同时，还通过有效的支持性护理优化生活质量，二者齐头并进。支持性治疗是骨髓瘤患者治疗管理的重要组成部分，因为它旨在提高患者的生活质量，也有助于提高生存率。本综述的目的是强调生活质量、支持性护理与生存率提高之间的关系。
利益冲突
未声明。
Zotero 插件